BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19489048)

  • 21. Association of dopamine D
    Komorowski A; Weidenauer A; Murgaš M; Sauerzopf U; Wadsak W; Mitterhauser M; Bauer M; Hacker M; Praschak-Rieder N; Kasper S; Lanzenberger R; Willeit M
    Neuroimage; 2020 Dec; 223():117270. PubMed ID: 32818617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose pramipexole causes D3 receptor-independent reduction of locomotion and responding for a conditioned reinforcer.
    McCormick PN; Fletcher PJ; Wilson VS; Browne JD; Nobrega JN; Remington GJ
    Neuropharmacology; 2015 Feb; 89():225-31. PubMed ID: 25283483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.
    McCormick PN; Wilson VS; Wilson AA; Remington GJ
    Pharmacol Res; 2013 Apr; 70(1):66-71. PubMed ID: 23327779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
    Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
    Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.
    Graff-Guerrero A; Mamo D; Shammi CM; Mizrahi R; Marcon H; Barsoum P; Rusjan P; Houle S; Wilson AA; Kapur S
    Arch Gen Psychiatry; 2009 Jun; 66(6):606-15. PubMed ID: 19487625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
    Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans.
    Le Foll B; Payer D; Di Ciano P; Guranda M; Nakajima S; Tong J; Mansouri E; Wilson AA; Houle S; Meyer JH; Graff-Guerrero A; Boileau I
    Neuropsychopharmacology; 2016 Jan; 41(2):529-37. PubMed ID: 26089182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.
    Caravaggio F; Kegeles LS; Wilson AA; Remington G; Borlido C; Mamo DC; Graff-Guerrero A
    Synapse; 2016 Nov; 70(11):453-60. PubMed ID: 27341789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of the preferential D
    Petragnano F; Fasciani I; Mannoury la Cour C; di Cara B; Aloisi G; Carli M; Kolachalam S; Rossi M; Marampon F; Scarselli M; Millan MJ; Maggio R
    Eur J Pharmacol; 2022 Jun; 925():175016. PubMed ID: 35545150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO.
    Tateno A; Sakayori T; Kim WC; Honjo K; Nakayama H; Arakawa R; Okubo Y
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):522-527. PubMed ID: 29346639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET Imaging of Pancreatic Dopamine D
    Bini J; Sanchez-Rangel E; Gallezot JD; Naganawa M; Nabulsi N; Lim K; Najafzadeh S; Shirali A; Ropchan J; Matuskey D; Huang Y; Herold KC; Harris PE; Sherwin RS; Carson RE; Cline GW
    J Nucl Med; 2020 Apr; 61(4):570-576. PubMed ID: 31601695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO.
    Caravaggio F; Nakajima S; Borlido C; Remington G; Gerretsen P; Wilson A; Houle S; Menon M; Mamo D; Graff-Guerrero A
    Neuropsychopharmacology; 2014 Nov; 39(12):2769-76. PubMed ID: 24874713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.
    Gallezot JD; Zheng MQ; Lim K; Lin SF; Labaree D; Matuskey D; Huang Y; Ding YS; Carson RE; Malison RT
    J Nucl Med; 2014 Jun; 55(6):960-6. PubMed ID: 24732151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.
    Nakajima S; Caravaggio F; Boileau I; Chung JK; Plitman E; Gerretsen P; Wilson AA; Houle S; Mamo DC; Graff-Guerrero A
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1812-8. PubMed ID: 26058690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated Dopamine D
    Gaiser EC; Gallezot JD; Worhunsky PD; Jastreboff AM; Pittman B; Kantrovitz L; Angarita GA; Cosgrove KP; Potenza MN; Malison RT; Carson RE; Matuskey D
    Neuropsychopharmacology; 2016 Dec; 41(13):3042-3050. PubMed ID: 27374277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors.
    Seeman P; Guan HC
    Synapse; 2009 Aug; 63(8):705-9. PubMed ID: 19391149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine receptors labelled by PHNO.
    Seeman P; Ulpian C; Larsen RD; Anderson PS
    Synapse; 1993 Aug; 14(4):254-62. PubMed ID: 7902615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.